1
/
of
0
FDA FAERS Reports – Winrevair (Sotatercept) Oct 2024
FDA FAERS Reports – Winrevair (Sotatercept) Oct 2024
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: Full reports of any and all adverse events reported to the FAERS database for Winrevair (branded name / marketed by Merck) or sotatercept (generic name) between October 1, 2024 and October 31, 2024. Please provide the documents electronically if possible.
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details